Obesity and cellulitis: Associations with infection severity, recurrence, and healthcare utilization—A systematic review
- 1Department of Internal Medicine, SUNY Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, NY, 11203, USA
- 2NewYork-Presbyterian Brooklyn Methodist Hospital, 506 6th Street, Brooklyn, NY, 11215, USA
Abstract
Background: Obesity is a growing global health concern associated with chronic inflammation, immune dysregulation, and impaired skin barrier function, all of which may increase susceptibility to cellulitis and influence clinical outcomes. This systematic literature review synthesized current evidence examining the relationship between obesity and cellulitis risk, infection severity, and healthcare utilization.
Methods: This PRISMA 2020-guided systematic review and narrative synthesis searched PubMed/MEDLINE, Embase, CINAHL, and Web of Science for English-language primary studies published from January 2015 through December 2025. Eligible studies involved adults with cellulitis or erysipelas—or adult population cohorts reporting a separable cellulitis/erysipelas-specific outcome—evaluating body mass index (BMI) or obesity as an exposure or predictor. Target outcomes comprised cellulitis development or hospitalization, recurrence, treatment response or failure, severity, length of stay, readmission, cost, and mortality. Given the substantial heterogeneity across study designs and outcome definitions, findings were synthesized narratively. When sufficiently complete primary reports were available, risk of bias was evaluated using design-appropriate Joanna Briggs Institute (JBI) critical appraisal tools (Appendix 4).
Results: Eighteen primary studies met the eligibility criteria. Across population cohorts and cellulitis-specific clinical studies, higher BMI or obesity was generally associated with greater cellulitis risk (e.g., ORs ranging from 1.11 to 4.7) and, in several studies, recurrence or increased healthcare utilization (such as prolonged length of stay). However, associations were not uniform: some studies reported null findings for treatment failure or readmission. The evidence base was predominantly observational and methodologically heterogeneous, so conclusions regarding downstream clinical outcomes are less certain than those regarding cellulitis risk and incidence.
Conclusion: Obesity is an important risk marker of cellulitis susceptibility and adverse clinical outcomes. Future studies using standardized outcome measures and improved assessments of adiposity beyond BMI are needed to guide prevention strategies and optimize management of this growing population.
Related
- Direct and indirect costs as barriers to maternal healthcare utilization among adolescent mothers in low- and middle-income countries: a systematic review
- Associations of Health Insurance, Household Income, and Cost-Related Healthcare Barriers With Routine Medical Checkup Utilization Among U.S. Adults: Evidence From the 2024 BRFSS
- Associations of multimorbidity burden with healthcare utilization and expenditures among individuals with diabetes in China
- Associations of Cancer Rehabilitation During Hospitalization for Cancer Treatment With Survival and Post–Discharge Healthcare Utilization: A Multicenter Retrospective Cohort Study
- Healthcare utilization and medical costs among adults with selected psychiatric disorders: a nationwide retrospective cohort study
BibTeX
@article{hanif2026obesity,
title = {{Obesity and cellulitis: Associations with infection severity, recurrence, and healthcare utilization—A systematic review}},
author = {Fariha Hanif and Toni-Ann Lewis and Michael Kaiser},
journal = {Obesity Pillars},
year = {2026},
month = oct,
doi = {10.1016/j.obpill.2026.100345},
url = {https://doi.org/10.1016/j.obpill.2026.100345},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Obesity and cellulitis: Associations with infection severity, recurrence, and healthcare utilization—A systematic review
AU - Fariha Hanif
AU - Toni-Ann Lewis
AU - Michael Kaiser
PY - 2026
DA - 2026/10/13
JO - Obesity Pillars
DO - 10.1016/j.obpill.2026.100345
UR - https://doi.org/10.1016/j.obpill.2026.100345
AB - Background: Obesity is a growing global health concern associated with chronic inflammation, immune dysregulation, and impaired skin barrier function, all of which may increase susceptibility to cellulitis and influence clinical outcomes. This systematic literature review synthesized current evidence examining the relationship between obesity and cellulitis risk, infection severity, and healthcare utilization. Methods: This PRISMA 2020-guided systematic review and narrative synthesis searched PubMed/MEDLINE, Embase, CINAHL, and Web of Science for English-language primary studies published from January 2015 through December 2025. Eligible studies involved adults with cellulitis or erysipelas—or adult population cohorts reporting a separable cellulitis/erysipelas-specific outcome—evaluating body mass index (BMI) or obesity as an exposure or predictor. Target outcomes comprised cellulitis development or hospitalization, recurrence, treatment response or failure, severity, length of stay, readmission, cost, and mortality. Given the substantial heterogeneity across study designs and outcome definitions, findings were synthesized narratively. When sufficiently complete primary reports were available, risk of bias was evaluated using design-appropriate Joanna Briggs Institute (JBI) critical appraisal tools (Appendix 4). Results: Eighteen primary studies met the eligibility criteria. Across population cohorts and cellulitis-specific clinical studies, higher BMI or obesity was generally associated with greater cellulitis risk (e.g., ORs ranging from 1.11 to 4.7) and, in several studies, recurrence or increased healthcare utilization (such as prolonged length of stay). However, associations were not uniform: some studies reported null findings for treatment failure or readmission. The evidence base was predominantly observational and methodologically heterogeneous, so conclusions regarding downstream clinical outcomes are less certain than those regarding cellulitis risk and incidence. Conclusion: Obesity is an important risk marker of cellulitis susceptibility and adverse clinical outcomes. Future studies using standardized outcome measures and improved assessments of adiposity beyond BMI are needed to guide prevention strategies and optimize management of this growing population.
SN - 2667-3681
ER -